By Jason Derry --
Reliance Life Sciences has
announced that it will buy a controlling share of GeneMedix Plc. UK-based
GeneMedix is a biopharmaceutical company whose core technology involves
"protein development scale-up and manufacture" (see link). Reliance Life Sciences, based in India, "is developing business
opportunities in the domains of medical biotechnology, plant biotechnology,
industrial biotechnology, clinical research services and contract
manufacturing" (see link). Reliance's investment is reported to be $63.2
million.
Jason Derry, Ph.D., who graduated with honors from DePaul University
College of Law, is a molecular biologist and founding author of Patent Docs.
Compare the US patent system with European patent system.
Posted by: wahid | March 08, 2008 at 02:59 AM
. Which works are protected by copyright? What are the two basic conditions for the protection of a work? Can X get copyright for something that has been created by Y before? If so, under what conditions?
Posted by: wahid | March 08, 2008 at 03:02 AM
Why is Collective Management necessary in the exercise of copyright and related rights? What rights are commonly taken care of by the Collective Management Organisations (CMOs)? What is the difference between Rights Clearance Centres and One-Stop Shops for collective management?
Posted by: tanweer | March 08, 2008 at 03:05 AM
Wahid & Tanweer:
Patent Docs, as you can probably tell from our name, focuses on patent issues (and more specifically on biotech and pharma patent issues). There are, however, a number of copyright-related blogs that may be able to answer your questions.
Donald Zuhn
Posted by: Donald Zuhn | March 08, 2008 at 10:40 AM